QUICK LINKS for Busy People
![]() –MONDAY–
AAIE's COVID-19 BRIEFING #148 Data and Ideas to Support Your Crisis Leadership
December 9, 2020
–TODAY'S BRIEFING HIGHLIGHTS– 68,674,375 identified cases (Johns Hopkins)
–TODAY's QUOTE– ![]()
–TOMORROW'S CONVERSATION– with International School Leaders from Around the World
THURSDAY December 10 8:00AM EST OUR WEEKLY CONVERSATION SCHOOL HEADS AND SENIOR LEADERS AROUND THE WORLD #41 – hosted by Will Richardson Join our weekly CONVERSATION between School Heads and Senior Leaders. Our discussions continue to be contemporary, important and a time we teach each other. Thanks to Will Richardson who has facilitated each Thursday since the very beginning.
![]()
Follow-up From Today's CONVERSATION –SUPPORTING EACH MEMBER OF OUR LEADERSHIP TEAM AND THEIR LEARNING– Leading from the Middle ![]() ![]() Ewan McIntosh, NoTosh ![]() Editor's Note: Today, Ewan McIntosh highlighted the rationale for the NOTOSH and AAIE partnership for bringing middle leaders into a leadership curriculum to support their work. With important insight, we focused on six key skill sets the middle leaders must develop to fully support the school they help lead. And to do so without being buried by the bureaucracy of management. If you missed today, allow me to commend you to review the VIDEO and the SLIDE DECK. And the SLIDE DECK offers a guided tour! We will provide a sign-up for your leadership team to join in on the Leading from the Middle leadership curriculum, beginning in January 2021. ![]() ![]() 12 Lessons in Leadership in a Year to Forget –by Dr. David Willows, International School of Brussels
I’ll be honest, when I asked the grade 4 students in my class back in 2001, to imagine the experience of school in 2020, none of them were even close.
There is no doubt that, for many of us, we will remember this year as one to forget. But before we file it away under Life’s Least Wanted, I’m going to have one last attempt at extracting some of the lessons in school leadership that I’ve learned along the way.
It’s not an exhaustive list. It’s not even an entirely serious list. But one or two of these lessons may just cause you to nod in agreement or give rise to a wry smile.
So, here goes. ![]() David Willows ![]() ![]() ![]() ![]() January February March April May June July August September October November December –TODAY's POEM TO CONSIDER–
A poem, just for you ... (thank you Bob Hetzel)
Instructions for the Journey
The self you leave behind is only a skin you have outgrown. Don’t grieve for it. Look to the wet, raw, unfinished self, the one you are becoming. The world, too, sheds its skin: politicians, cataclysms, ordinary days. It’s easy to lose this tenderly unfolding moment. Look for it as if it were the first green blade after a long winter. Listen for it as if it were the first clear tone in a place where dawn is heralded by bells. And if all that fails, wash your own dishes. Rinse them. Stand in your kitchen at your sink. Let cold water run between your fingers. Feel it. — Pat Schneider
Sharing A Feel Good Video ...because we can and because we should! STAY FOCUSED ON COVID-19 SCIENCE
FROM STATnews To defeat Covid-19, we must acknowledge the fear it engenders Fear — gut-wrenching, all-consuming fear, like the fear of dying from a horrific respiratory virus — can be much more powerful than science.
Research advances knowledge and public health and medical guidance change to follow. But that simply doesn’t play well when you are being closely analyzed by a frightened and distrustful public.
A fascinating article on the role fear plays in increasing the impact of a global pandemic, especially if you are on the frontline. (a personal account and a classic case of what is perceived...is)
FROM Nature Oxford COVID-vaccine paper highlights lingering unknowns about results
The first formally published results from a large clinical trial of a COVID-19 vaccine — which scientists hope could be among the cheapest and easiest to distribute around the world — suggest that the vaccine is safe and effective. But the data also highlight a number of lingering unknowns, including questions about the most effective dosing regimen and how well it works in older adults.
The news is good, but we're not out of the woods yet A Fresh Take on School Quarantine and Isolation ![]() Rick Weinland and friend –by Rick Weinland Head of School Commonwealth-Parkville School San Juan, Puerto Rico
Like so many schools around the world, we have been delivering our academic program via distance learning since mid-March. Although we had expected and hoped to start our new school year in a hybrid fashion in August, the government here has not yet allowed schools to open. We have, however, been fortunate this semester to have access to our two campuses, enabling our faculty to take advantage of high speed internet, availability of classroom resources, and opportunities for collaboration. We redesigned our program over the summer, and our entire faculty and staff, together with our 700 students and their families, have stepped up to the challenge of distance learning, not knowing when -- or even if -- we will return to the classroom this year. ![]() We are grateful for the wisdom shared by international school leaders around the world who have been the early adopters in the cycle of lockdown, hybrid reopening, and full face-to-face learning (in some cases for a second time!). We now look ahead with both excitement and uncertainty towards the vaccination process, which will surely present a whole new set of challenges.
As the virus continues to spread, and our faculty and staff (or their family) either travel or host visitors, or have close contact (or live) with a Covid case, we typically have a few of our people in various stages of quarantine. The CDC has been diligent in updating their Covid-19 protocols, but determining exactly which scenario is appropriate takes some navigation through various CDC pages. In search of a quick guide we created a one-page reference sheet, which we use with our nurses and faculty/staff. This is only used as a guide - in all cases the advice of local health experts and individual doctors comes first, and we know these protocols are a moving target. Indeed, we added the recent 7/10 day quarantine option announced by the CDC last week, and will surely be adjusting it again in the weeks and months ahead. I share it in case it might be of use to others. –THE NEWS of COVID-19– 68,674,375 Cases Worldwide (Johns Hopkins CSSE)
First the UK, then Canada, Soon the USA The coronavirus vaccine developed by Pfizer and its partner BioNTech has moved one step closer to approval for emergency use in the US. The US Food and Drug Administration (FDA) released documents today, which said figures on the vaccine’s safety and efficacy meet its expectations for emergency use authorization. The documents said the two-dose vaccine is highly effective at preventing confirmed cases of Covid-19 at least seven days after the first dose. They also said there wasn’t enough data to conclude whether the vaccine is safe in people under 16, people who are pregnant and those whose immune systems are compromised. The agency is expected to make a decision on whether to authorize the vaccine within days or weeks. (New Scientist)
70% Effectiveness Oxford University and AstraZeneca on Tuesday became the first Covid-19 vaccine makers to publish final-stage clinical trial data in a scientific journal, clearing a key hurdle in the global race to produce safe and effective drugs for the coronavirus. The study, published in the respected Lancet medical journal, confirmed that the vaccine works in an average of 70 percent of cases. (Science Alert, The Lancet)
Covid-19 Live Updates: Chinese Vaccine Is Called 86 Percent Effective, Nearly Matching Western Rivals The United Arab Emirates approved a Chinese coronavirus vaccine on Wednesday, citing preliminary data showing that it was 86 percent effective. The move, the first full approval of a Chinese vaccine by any nation including China, could bring the vaccine a step closer to widespread use around the world.
The announcement by the Emirates’ Ministry of Health and Prevention was the first official indicator of a Chinese vaccine’s potential to help stop the pandemic. If trials elsewhere produce similar findings, the Chinese vaccines could offer a lifeline to developing countries that cannot afford vaccines developed in Western nations that are likely to be more expensive and more difficult to store and distribute.
Chinese government officials and Sinopharm, the state-owned maker of the vaccine, were silent on Wednesday about the Emirati announcement. Scientists noted that the announcement was lacking in data and other critical details.
Sinopharm would not confirm or comment on the news, even hours after it was reported. A spokeswoman for the company hung up the phone when reached and did not respond to messages and calls afterward.
The news release from the Emirati government did not give important specifics, like the number of Covid-19 cases that were analyzed or the ages of volunteers, leaving it unclear to scientists how Sinopharm came to its conclusions about the vaccine’s effectiveness. (New York Times)
The Worries of Germany's Angela Merkel Chancellor Angela Merkel pleaded with Germans to meet fewer people and stay at home over the holidays in an impassioned speech to lawmakers on Wednesday, as her country saw a record number of deaths from the coronavirus.
“I’m sorry, from the bottom of my heart, I am really sorry,” the visibly emotional chancellor said during a budget debate in Parliament. “But if the price we pay is 590 deaths a day then I have to say this is not acceptable.”
Ms. Merkel, a physicist who won praise in the spring for her detailed explanations of the science behind why Germans needed to stay at home, was frustrated five weeks ago when the governors of the country’s 16 states agreed only to partial restrictions that left most stores and schools open.
The result has been stubbornly high numbers of new infections and record numbers of people dying from the virus — as many in the first seven days of December as died in traffic accidents across the country in all of 2019, according to a report by Germany’s National Academy of Sciences that urged a strict lockdown over Christmas and New Year's Eve
Through early testing, contact tracing and a coordinated effort from all levels of government, Germany emerged from the first wave of the virus with relatively few fatalities and enough intensive care beds to take on patients from neighboring countries.
But even as other European countries, including Belgium, France and Ireland, returned to severe restrictions on movement in October, Germany’s governors continued to squabble over how best to handle the virus, citing the different experiences in their regions. (New York Times)
A Paper-based COVID Testing As the COVID-19 pandemic continues to spread across the world, testing remains a key strategy for tracking and containing the virus. Bioengineering graduate student, Maha Alafeef, has co-developed a rapid, ultra-sensitive test using a paper-based electrochemical sensor that can detect the presence of the virus in less than five minutes. The team led by professor Dipanjan Pan reported their findings in ACS Nano. (vScience Daily, ACS Nano)
The USA Tragedy Continues The number of people hospitalized in the U.S. hit another all-time high as the nation reported more than 192,000 new coronavirus cases. More than 102,000 people were hospitalized due to Covid-19 around the country on Monday, according to the Covid Tracking Project. The number of people in intensive care units declined slightly from the record hit the previous day to 20,098. In California, the number of newly reported coronavirus cases declined from the record reached on Sunday, but remained elevated at more than 24,000 in a single day, according to data compiled by Johns Hopkins University. (via The Wall Street Journal)
A Universal Flu Vaccine A “universal” flu vaccine has gone through the first stage of human trials, in a crucial step towards pandemic-proofing the planet. The vaccine, designed to work against influenza even if the virus mutates, has passed phase one trials, showing it is safe and results in antibodies. In the 65 recipients, who were followed over 18 months, it created a “broad, strong, durable and functional immune response”, the scientists found. If it can be proven to work at a larger scale then it could replace the annual flu jab, and protect against dangerous strains that have yet to appear. (via Times of London)
The Equity of Access Debate Begins South Africa and India have called for the World Trade Organization (WTO) to suspend intellectual property (IP) rights related to COVID-19 to ensure that not only the wealthiest countries will be able to access and afford the vaccines, medicines, and other new technologies needed to control the pandemic. The pharmaceutical industry and many high-income countries (HICs) staunchly oppose the move, which they say will stifle innovation when it is needed most. (The Lancet)
One Year Since 'First' COVID-19 Symptoms in China It has been a year since the first person confirmed to be infected with the coronavirus in Wuhan, China, is believed to have begun exhibiting symptoms.
Chinese authorities have said the person developed pneumonia on December 8, 2019. One year later, it is still unclear where the virus came from and how it was transmitted to humans.
In February, Chinese government experts said the virus is likely to have originated in bats and jumped to humans via pangolins. But they later suggested the virus was detected in food imports, so they couldn't rule out the possibility that it was brought in from abroad.
In July, the World Health Organization sent an investigative team to Beijing as part of efforts to identify the origin of the virus. But they have yet to conduct a detailed survey in Wuhan. There has been concern from the international community about what seems to be China's uncooperative stance on exploring the cause of the virus. (NHK-World, Japan)
–The STATS–
TODAY's TOTAL GLOBAL CASES:
Johns Hopkins– 68,674,375
WHO–67,780,361
TOTAL GLOBAL DEATHS (WHO):
Today–1,551,214
Two Days Ago–1,500,614
EVOLUTION OF-GLOBAL CASES (WHO):
Today–67,780,361
Two Days Ago– 64,603,428
NEW CASES (WHO): 546,703
–Tracking the Virus Around the World– ![]()
–FROM JOHNS HOPKINS CSSE–
The Cultures of Dignity Resources for Supporting Social-Emotional Wellness
![]()
A Final Note: The AAIE COVID-19 Briefing is provided to support your leadership for the school community you serve. We encourage you to use these resources in any way, shape or form that helps you, your communications and toward furthering close relationships across your community. – The AAIE Board |